MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose

被引:29
作者
Emborg-Knott, ME [1 ]
Domino, EF [1 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
dopaminergic agonists; neurotoxicity; parkinsonism; substantia nigra;
D O I
10.1006/exnr.1998.6845
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Five female adult Macaca nemestrina monkeys, given a unilateral intracarotid (ic) infusion of 2.3-3.5 mg of MPTP-HCl, were studied for 6-8 years. Two to 3 days after MPTP the animals developed hemiparkinsonism characterized by rigidity and flexed posture of the arm contralateral tea the side of infusion with episodes of tremor, circling ipsilateral to the lesioned side, a slight balance disturbance, and stooped posture. Rating of parkinsonian features 4 months after ic infusion, and yearly thereafter did not show any statistically significant changes. The animals maintained their usual appetite and body weight increased normally. Each animal responded to L-DOPA methyl ester with decreased parkinsonian signs and symptoms and increased contralateral turning. In contrast, after control vehicle administration, the animals continued to have the same parkinsonian signs and predominant ipsilateral turns. In three of the five monkeys, contralateral turns after vehicle significantly increased after 6-8 years. Unilateral intracarotid MPTP induced asymmetric motor behavior that remained stable after 6-8 years. Animals that showed an increased frequency of contralateral circling after control vehicle showed a decrease in contralateral turns after L-DOPA methyl ester, suggesting neuroplastic changes over the years. (C) 1998 Academic Press.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 36 条
[1]   VALUE AND APPROPRIATE USE OF RATING-SCALES AND APPARATIVE MEASUREMENTS IN QUANTIFICATION OF DISABILITY IN PARKINSONS-DISEASE [J].
BAAS, H ;
STECKER, K ;
FISCHER, PA .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 5 (01) :45-61
[2]  
BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5
[3]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[4]  
CALNE DB, 1994, MOV DISORD, V9, P76
[5]  
CHIVERS DJ, 1985, ROAD SELFSUSTAINING, P136
[6]  
*COMM CAR US LAB A, 1985, NIH PUBL, P1
[7]   INVIVO IMAGING OF MONOAMINERGIC NERVE-TERMINALS IN NORMAL AND MPTP-LESIONED PRIMATE BRAIN USING POSITRON EMISSION TOMOGRAPHY (PET) AND [C-11] TETRABENAZINE [J].
DASILVA, JN ;
KILBOURN, MR ;
DOMINO, EF .
SYNAPSE, 1993, 14 (02) :128-131
[8]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[9]  
DEUZEN DE, 1996, J NEUROCHEM, V66, P658
[10]  
Domino E. F., 1996, Society for Neuroscience Abstracts, V22, P2126